Dr. Li Zhang, MD
Claim this profileSun Yat-sen University Cancer Center
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
28 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
MET positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials Li Zhang, MD is currently running
TROP2 ADC
for Cancer
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies. Patient must have historically documented, incurable, locally advanced or metastatic cancer that are refractory to standard therapies of one of the following types: 1. Triple negative breast cancer 2. Epithelial ovarian cancer 3. Non-small cell lung cancer 4. Gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma 5. Small cell lung cancer 6. HR+/ HER2-breast cancer 7. Head and neck squamous cell carcinoma 8. Endometrial carcinoma 9. Urothelial carcinoma
Recruiting1 award Phase 1 & 213 criteria
PRO1160
for Advanced Cancer
This trial tests PRO1160, a targeted cancer treatment, in patients with advanced or hard-to-remove cancers. PRO1160 uses an antibody to find cancer cells and a drug to kill them.
Recruiting1 award Phase 1 & 25 criteria
More about Li Zhang, MD
Clinical Trial Related2 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Li Zhang, MD has experience with
- Placebo
- Gefitinib
- SKB264
- Carboplatin
- Pemetrexed
- Ensartinib
Breakdown of trials Li Zhang, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Nausea and Vomiting
Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Li Zhang, MD specialize in?
Li Zhang, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Li Zhang, MD currently recruiting for clinical trials?
Yes, Li Zhang, MD is currently recruiting for 2 clinical trials in Guangzhou Guangdong. If you're interested in participating, you should apply.
Are there any treatments that Li Zhang, MD has studied deeply?
Yes, Li Zhang, MD has studied treatments such as Placebo, Gefitinib, SKB264.
What is the best way to schedule an appointment with Li Zhang, MD?
Apply for one of the trials that Li Zhang, MD is conducting.
What is the office address of Li Zhang, MD?
The office of Li Zhang, MD is located at: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060 China. This is the address for their practice at the Sun Yat-sen University Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.